These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 17574402)

  • 1. In vitro skin absorption and drug release - a comparison of six commercial prednicarbate preparations for topical use.
    Lombardi Borgia S; Schlupp P; Mehnert W; Schäfer-Korting M
    Eur J Pharm Biopharm; 2008 Feb; 68(2):380-9. PubMed ID: 17574402
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drug release and skin penetration from solid lipid nanoparticles and a base cream: a systematic approach from a comparison of three glucocorticoids.
    Schlupp P; Blaschke T; Kramer KD; Höltje HD; Mehnert W; Schäfer-Korting M
    Skin Pharmacol Physiol; 2011; 24(4):199-209. PubMed ID: 21346400
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Esterase activity in excised and reconstructed human skin--biotransformation of prednicarbate and the model dye fluorescein diacetate.
    Bätz FM; Klipper W; Korting HC; Henkler F; Landsiedel R; Luch A; von Fritschen U; Weindl G; Schäfer-Korting M
    Eur J Pharm Biopharm; 2013 Jun; 84(2):374-85. PubMed ID: 23201050
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug targeting by solid lipid nanoparticles for dermal use.
    Santos Maia C; Mehnert W; Schaller M; Korting HC; Gysler A; Haberland A; Schäfer-Korting M
    J Drug Target; 2002 Sep; 10(6):489-95. PubMed ID: 12575739
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Galenic and clinico-pharmacologic studies of prednicarbate (Hoe 777)].
    Petri W; Frosch PJ; Savopoulos C; Rupp W; Sittig W
    Z Hautkr; 1986; 61 Suppl 1():62-73. PubMed ID: 3705674
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Pharmacokinetics and biotransformation following topical use of the local corticoid prednicarbate].
    Kellner HM; Eckert HG; Fehlhaber HW; Hornke I; Oekonomopulos R
    Z Hautkr; 1986; 61 Suppl 1():18-40. PubMed ID: 3705671
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Solid lipid nanoparticles as drug carriers for topical glucocorticoids.
    Maia CS; Mehnert W; Schäfer-Korting M
    Int J Pharm; 2000 Mar; 196(2):165-7. PubMed ID: 10699710
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of various pharmaceutical preparations of prednicarbate after repeated topical administration to the skin of rats.
    Vogel HG; Petri W
    Arzneimittelforschung; 1985; 35(6):939-46. PubMed ID: 4026921
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Skin penetration and metabolism of topical glucocorticoids in reconstructed epidermis and in excised human skin.
    Gysler A; Kleuser B; Sippl W; Lange K; Korting HC; Höltje HD; Korting HC
    Pharm Res; 1999 Sep; 16(9):1386-91. PubMed ID: 10496654
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Albumin effects on drug absorption and metabolism in reconstructed epidermis and excised pig skin.
    Haberland A; Santos Maia C; Jores K; Dürrfeld M; Mehnert W; Schimke I; Christ B; Schäfer-Korting M
    ALTEX; 2003; 20(1):3-9. PubMed ID: 12579349
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Study of tolnaftate release from fatty acids containing ointment and penetration into human skin ex vivo.
    Kezutyte T; Drevinskas T; Maruska A; Rimdeika R; Briedis V
    Acta Pol Pharm; 2011; 68(6):965-73. PubMed ID: 22125963
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prednicarbate biotransformation in human foreskin keratinocytes and fibroblasts.
    Gysler A; Lange K; Korting HC; Schäfer-Korting M
    Pharm Res; 1997 Jun; 14(6):793-7. PubMed ID: 9210199
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Studies on the pharmacokinetics and metabolism of prednicarbate after cutaneous and oral administration.
    Barth J; Lehr KH; Derendorf H; Möllmann HW; Höhler T; Hochhaus G
    Skin Pharmacol; 1993; 6(3):179-86. PubMed ID: 8274287
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Experimental results of the optimization of external prednisolone therapy].
    Wohlrab W; Taube KM; Wozniak KD
    Pharmazie; 1987 Jun; 42(6):400-2. PubMed ID: 3671461
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reconstructed skin equivalents for assessing percutaneous drug absorption from pharmaceutical formulations.
    Zghoul N; Fuchs R; Lehr CM; Schaefer UF
    ALTEX; 2001; 18(2):103-6. PubMed ID: 11378682
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of In Vitro and In Vivo Percutaneous Absorption Across Human Skin Using BAY1003803 Formulated as Ointment and Cream.
    Günther C; Kowal K; Schmidt T; Jambrecina A; Toner F; Nave R
    Clin Pharmacol Drug Dev; 2020 Jul; 9(5):582-592. PubMed ID: 31647607
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dermal penetration and metabolism of p-aminophenol and p-phenylenediamine: application of the EpiDerm human reconstructed epidermis model.
    Hu T; Bailey RE; Morrall SW; Aardema MJ; Stanley LA; Skare JA
    Toxicol Lett; 2009 Jul; 188(2):119-29. PubMed ID: 19446244
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative permeation studies of nondiluted and diluted betamethasone-17-valerate semisolid formulations through isolated human stratum corneum and artificial skin construct.
    Mitriaikina S; Muller-Goymann CC
    Skin Pharmacol Physiol; 2009; 22(3):142-50. PubMed ID: 19246962
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reconstructed epidermis and full-thickness skin for absorption testing: influence of the vehicles used on steroid permeation.
    Schäfer-Korting M; Mahmoud A; Lombardi Borgia S; Brüggener B; Kleuser B; Schreiber S; Mehnert W
    Altern Lab Anim; 2008 Sep; 36(4):441-52. PubMed ID: 18826333
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diffusion and metabolism of prednisolone farnesylate in viable skin of the hairless mouse.
    Tojo K; Yamada K; Hikima T
    Pharm Res; 1994 Mar; 11(3):393-7. PubMed ID: 8008705
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.